Absolute Lymphocyte Count, Platelet-to-Lymphocyte Ratio, and Overall Survival in Eribulin-treated HER2-negative Metastatic Breast Cancer Patients.
Cancer diagnosis & prognosis(2021)
摘要
ALC and PLR can predict eribulin efficacy in terms of OS, reflecting the antitumour immune response in the microenvironment and indicating eribulin's effectiveness.
更多查看译文
关键词
Eribulin,absolute lymphocyte count,metastatic breast cancer,neutrophil-to-lymphocyte ratio,overall survival,platelet-to-lymphocyte ratio,prognosis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要